The medicinal cannabis company, Bod Australia, has partnered with the University of Technology, Sydney, to explore the potential anti-aging effects of cannabis.
Bod Australia (ASX:BDA) recently revealed the preliminary results from the research collaboration, which has potentially isolated a new family of proteins found in human cells that act as powerful antioxidants.
In addition to this, the research undertaken by Bod has also shown that these proteins can be used as a delivery vehicle to carry molecules—like cannabidiol (CBD), which also has its own antioxidant qualities—into the body.
"The results of this three-year collaboration provide us a fantastic commercial opportunity in both the anti-ageing and cannabis markets which are both rapidly growing and ever changing,"
– Bod Australia CEO, Jo Patterson
"The company is in the position to develop a suite of products that utilise these novel proteins in combination with specific CBD extracts and other cannabis compounds, allowing for increased optionality over its broader product suite."
"This will position Bod with an IP protected and patentable product suite building greater value for the total business," Patterson said.
These findings come after three years of research by the two organisations, and may have broad ranging applications for both consumer products and therapeutic medicinal treatments.
According to the Chief Scientific Officer of Bod Australia, Adele Hosseini, these proteins possess certain antioxidant qualities which could potentially be used to protect the skin from the effects of the ageing process.
"Proteins are large complex molecules, they play many critical roles in the body. They do most of the work in cells and they are required for the structure, function and regulation of the body. They can work as antibodies, enzyme, have different functions. This family of proteins have this characteristic that they can work as an antioxidant," Hosseini said.
"This is only the first phase that we can reveal but it is very promising. The next phase of this research is to see how we can bring it up and make products that you can commercialise."?
"Skincare is quite popular [at] any age. So we are not limiting ourselves to any particular age group."
Hosseini also believes that certain rules surrounding cannabis research should be relaxed by the Australian government, saying that the regulatory environment is currently "quite dynamic" and prone to sudden change.
"We especially we think that the rules need to be relaxed a lot more around the non-psychoactive cannabinoids because they have definitely proved to have fewer side effects."
"And it can benefit a wide group of patients and people in general," Hosseini said.
The Acting Head for the UTS School of Life Sciences, Professor Stella Valenzuela, was also excited about the findings, saying that the discoveries were "extremely exciting and promising".
"They offer a number of new opportunities for translation of our research into products for use in the beauty and health care area," she said.
The present method used by the study involves combining the newly discovered proteins with CBD, which is then made into topical anti-ageing cream. Now that they have moved on to the commercialisation phase of their research, Bod will continue to work with UTS to explore further applications for the findings.
"It could be really something we can use for the application of pharmaceuticals. Specifically, we are working with medicinal cannabis, so we are planning to use this as a delivery system to the body for CBD and other cannabinoids that may be discovered in the future," Bod Chief Scientific Officer Adele Hosseini said. ?
"This is just the start. The more it is used, it can be filtered to see what is the actual important effects of CBD or other cannabinoids."?
"There is a huge opportunity for these products to serve the community, whether as an anti-ageing product or a therapeutic agent to cure some skin conditions. There's absolutely potentials to treat other skin conditions, like acne, inflammation or more severe conditions like psoriasis."?
& Keep Up to Date
Get the latest pot stock recommendations, cannabis news
and industry updates straight to your inbox!